Cobalt chrome, Cobalt poisoning, DePuy, DePuy ASR Hip, depuy hip recall, DePuy Hip Recall Litigation, DePuy Lawsuit, DePuy Orthopaedics, FDA, Johnson, Johnson & Johnson, Los Angeles, Metal on metal hip, metal-on-metal hips, metallosis, New Jersey, Smith & Nephew, UNited States
DePuy Trial Continues Despite Talks of Settlement – Florida Mass Tort Attorneys, Lawyers | Searcy Mass Torts.
DePuy Trial Continues Despite Talks of Settlement
As the product liability trial over the DePuy ASR (Johnson & Johnson) metal-on-metal hip implants gets underway in Los Angeles, there comes a report that Johnson & Johnson is negotiating a potential settlement with the injured that could cost the company more than $2 billion. Businessweek says it checked with five sources in the matter to prepare the report.
However, Steven J. Skikos, co-lead counsel of the Plaintiffs’ Executive Committee, denies there are any settlement talks.
“The lawyers and leadership in the cooperating jurisdictions (the Federal Multi District Litigation, California, New Jersey, and Illinois) are working for the benefit of the 35,000 United States patients who have this recalled medical device. Any comment relating to settlement that does not come from leadership, or the court, or from the company itself, is speculative and uninformed,” he said in an issued statement, adding that right now the focus is on trial preparation.
By way of background you’ll recall there were about 93,000 DePuy metal-on-metal hips made by J&J recalled in August of 2010, including 37,000 in the U.S.
The problem – a failure rate that exceeded 12 percent within five years.
Our clients claim permanent injuries, bone fractures, metal debris left behind, as well as tissue death around the implant site, also known as adverse local tissue reaction (ALTR) or adverse reaction to metal debris (ARMD). Chromium and cobalt components can shed debris that enters the bloodstream and may also put the patient at risk for bladder and kidney cancers.
According to the FDA, there are risks inherent with any hip implant but metal-on-metal (MoM) hips have additional problems. Unfortunately, the FDA says it does not have enough information to understand the full extent to which metal debris accumulation causes symptoms or illness. However, as of January 2013, the agency said it does not believe a patient with a metal hip needs to undergo routine metal ion blood level checks if their doctor feels the hip is functioning properly.
As is customary, a J&J company spokeswoman issued a statement, “DePuy believes the evidence to be presented at trial will show the company acted appropriately and responsibly.” Businessweek reports that, according to a filing with the Securities and Exchange Commission, the company has increased its reserves in anticipation of liability litigation costs.
Besides the trial in Los Angeles that is underway there are about 10,000 lawsuits pending with most of the pretrial evidence consolidated in Toledo, Ohio. Attorneys involved in the litigation say they deposed more than 50 witnesses and reviewed more than 50 million pages of documents.
Next month another trial is expected to start in Chicago, and a third is scheduled in federal court in May, also in Toledo, Ohio. And next year expect a round of DePuy Pinnacle lawsuits to be heard. The Pinnacle was the successor to the ASR and ultimately those cases could far outnumber the ASR in that about 150,000 Pinnacle hips were implanted in U.S. patients.
The Pinnacle remains on the market.
- D’Oliveira & Associates Informs Clients of the Potential Risks of… (prweb.com)
- DePuy ASR Hip Lawsuit News: Expert Testifies on Toxicity of Metal Debris, Notes Bernstein Liebhard LLP (earlsview.com)
- DePuy Pinnacle Hip Lawsuits: Bernstein Liebhard LLP Notes New Order in Federal DePuy Pinnacle Litigation (earlsview.com)
- DePuy ASR Lawsuit Update: Toxicologist Testifies That Plaintiff Kransky Has High Levels of Metal in His Blood – Yahoo! Finance (earlsview.com)
- D’Oliveira & Associates Informs Clients of the Potential Risks of the Recalled DePuy ASR Hip Implant Device (virtual-strategy.com)
- DePuy ASR Trial Update: J&J Engineer-Suggested Redesign Meant to Minimize Metallic Debris Never Implemented, Parker Waichman LLP Reports – SFGate (earlsview.com)
- J&J Said to Offer Implant Pact That May Reach $2 Billion – Bloomberg (earlsview.com)
- Trial underway in hip implant lawsuit – latimes.com (earlsview.com)
- J&J Failed to Warn of Metal Hip Implant Flaws, Lawyers Argue (earlsview.com)
- Business: Washington Post Business Page, Business News (earlsview.com)
Thanks you for the update. I find it hard to swallow the FDA’s comments regarding not having enough information to understand the full extent to which metal debris accumulation causes symptoms or illness;
There is enough information of recent that would indicate the elevated chromium and cobalt blood levels could present a problem and do have a correlation with adverse hip conditions.
If the FDA doesn’t have a enough information to understand this issue what the HELL
ARE THEY DOING PLAYING WITH MY LIFE.
In the application of Smith & Nephew’s Birmingham Hip Resurfacing Device ( BHR )
in the very meeting held in Washington D.C. September, 08, 2005 to approve this device PMA, there were significant comments made by the voting party panel members as to the concern of lack of data and the unknown results as to the adverse affects the metal particles could have on the human body once entering the blood stream. Yet the FDA passed the PMA on the BHR with the word of ONE INVESTIGATOR-INVENTOR-Principal.
The FDA expressed concerns for lack of information on the metal debris matter
yet they looked at innovation first and SAFETY not.
The FDA’s comment about a patient with metal hip needs to undergo routine metal ion blood level checks if the doctor feels the hip is functioning properly:
BULL-SH-T, I had multiple x-rays, scans tests etc. Perhaps had I had my blood levels checked and an MRI I wouldn’t be in a wheelchair.
The scary part of this debacle is no one knows the future health outcome to folks that have been exposed to the metal debris, cancer, heart etc. etc.
So, once again I SAY TO THE FDA WHY DID YOU APPROVE THESE METAL ON METAL DEVICES WHEN THERE WAS NO SUFFICIENT AND VERIFYABLE ANSWERS TO THE METAL DEBRIS ISSUE.
THE FDA WAS SOLD A BILL OF GOODS ON DEIVES THAT WEREN’T TESTED PROPERLY IF AT ALL AND DID THE FDA EVEN VERIFY THE INFORMATION SUPPLIED TO THEM BY THE MANUFACTURER WHEN APPLICATIONS FOR APPROVALS WERE SUBMITTED AND IF SO HOW DID THEY VERIFY THE INFORMATION ???
Pingback: Iowa Resident Brings Suit Against Stryker For Damages Caused By Recalled Hip Implant – News Press Release | PharmiWeb.com | Earl's View
Pingback: Yeah, right…. J&J’s Floyd Says Hip Sales Halted for Business Reasons – Bloomberg | Earl's View
Pingback: RLG Responds to Report of Higher Metal-on-Metal Hip Replacement Failure Rates in Women | Earl's View
Pingback: DePuy Pinnacle Hip Replacement Lawsuits: Bernstein Liebhard LLP Comments on New Study Finding that Hip Replacement Failure More Likely in Women | Earl's View